The effect of NIgF of human milk on bacterial adherence to guinea pig intestinal tract was quantitatively determined with the use of radiolabeled bacteria.
Bacteria. ETEC strains isolated from humans with severe watery diarrhea were used. E. coli H10407 and E1392-75 were obtained from J. Holmgren , University of Goteborg, Sweden, 130 ABSTRACf. The protecting effect of human milk against intestinal infections has been well documented, but its mechanism not completely understood. We have examined the effect of the nonimmunoglobulin fraction (NIgF) of human milk and colostrum on bacterial adherence to the intestinal tract. The NlgF was prepared by passing the milk through an immunosorbent column containing rabbit antihuman -y-globulin (IgG and IgA). The effluent fraction did not contain -y-globulins as shown by immunodiffusion on agarose and by using rabbit antihuman Ig, that was then detected with fluorescently-labeled goat antirabbit Ig. The effect of the NIgF of human milk on the adherence of enterotoxigenic Escherichia coli strains to guinea pig intestinal tract was Quantitativelydetermined using radiolabeled bacteria which were incubated with suspensions of viable intestinal cells. Thirteen to 17 bacteria adhered per intestinal cell. NIgF of human milk and colostrum (300 Ill, 6.7 mg) caused about 50% inhibition of the adherence of enterotoxigenic E. coli strains whose attachment was mediated by colonization factor antigen I and II. No inhibition was noted on the adherence of enterotoxigenic E. coli strains containing type I pili. The inhibitory activity resisted boiling and proteolytic digestion with trypsin, but was completely abolished by periodate treatment, indicating that carbohydrate residues were probably involved. Examination of the effect of NIgF of human milk on bacterial adherence to intact intestinal surfaces revealed comparable results. Observations with scanning electron microscopy confirmed, morphologically, the attachment of the bacteria and the inhibitory effect of human milk. It is concluded that receptor-like glycocompounds in human milk and colostrum inhibit the adherence of certain enterotoxigenic E. coli strains to the intestinal mucosa. This may play a role in protecting infants against intestinal infections. (Pediatr Res 22: 130-134, 1987) Abbreviations ETEC, enterotoxigenic Escherichia coli GI, gastrointestinal SIgA, secretory IgA CFA, colonization factor antigen PBS, phosphate-buffered saline NIgF, nonimmunoglobulin fraction Several studies have shown that breast-feeding protects against GI infections (1-3) , and a committee who reviewed the literature concluded that association exists between breast-feeding and decreased rate of GI illness (4) . The protective effect of human milk is usually attributed to its high content of Ig, especially SIgA. However, Ig may be destroyed before reaching the small intestine, and as their titer is dependent on exposure of the mother to infectious microorganisms (5), it was suggested that their importance in developed countries is limited (6) . Human milk contains other defense factors, such as lactoferrin (7), lysozyme, T and B lymphocytes, and phagocytes (5), but their biological significance has not as yet been clarified.
Bacterial adherence to epithelial surfaces has been increasingly studied in recent years and has been recognized as an important prerequisite for infection (8) (9) (10) . Attachment to the intestinal mucosa is an obligatory pathogenic event in GI infections caused by enterotoxigenic bacteria, as it enables resistance to expulsion by peristaltic clearing mechanism, with subsequent enterotoxin production. Adherence is usually mediated by binding of bacterial surface proteins, called adhesins or lectins, to mammalian cell receptors (9, 10) . Several surface antigens have been isolated from bacterial pathogens of animals (K88 and K99 antigens) and man (type I pili and CFA) (11). The host surface receptors are usually sugar residues, probably glycoproteins or glycolipids on cell membranes (9) . This explains the competitive inhibitory effect of several carbohydrates on the adherence of specific bacteria (9, (12) (13) (14) . Since human milk is rich in free oligosaccharides, glycoproteins, and glycolipids (15) , and since its protection against gastroenteritis is not completely understood, it is possible that these compounds might be structural analogues to the intestinal receptors for bacterial pathogens and inhibit adherence. Indeed, Holmgren et al. (6) have shown that human milk inhibited Escherichia coli and Vibrio cholerae hemagglutination (6), which is dependent on bacterial attachment to erythrocytes.
We have recently described a system for studying bacterial adherence to guinea pig intestinal tract (13, 14, 16 ). Herein we have directly examined the effect ofNIgF of human milk on the adherence of ETEC strains to the gut. Lowry et al. (19) and the sugar content as described by Dubois et al. (20) .
RESULTS
The NIgF of human milk and colostrum , which were used throughout the study, were analyzed. The dry weight was similar (22.4-22.6 mg/rnl), and their protein and sugar content are shown in Table I .
Morphological observations with scanning electron microscopy clearly demonstrated that the bacteria examined adhered well to the microvillous surface of the small intestine, with reduction of the attachment by incubation with the NIgF of human milk. In Figure I the attachment of E. coli EI392 to the surface of the jejunum is demonstrated.
Adh erence 10 intestinal cells. Quantitative determinations showed that the attachment of the bacteria examined was 13-17 bacteria per cell. Adherence was temperature (optimal 37" C) and pH (optimal 6.2) dependent. Addition of NIgF of human milk or colostrum caused significant inhibition of the adherence of E. coli E 1392 and H 10407 (Fig. 2) , bacteria which possessed CFA/I or CFA/Il. The inhibitory effect of human milk and colostrum samples was similar, reducing the attachment of these bacteria to intestinal cells by approximately 50%. On the other hand, no inhibition was noted on the attachment of E. coli 0 128, which possessed man nose-sensitive type I pili and not CFA (Fig.   2 ).
The influence of the amount of human milk added on the Human colostrum Human milk Determinant icals, Uppsala, Sweden) (13, 14) . The layer of epithelial cells with the adhered bacteria was collected and counted for radioactivity and the number of bacteria which adhered to the intestinal cells was quantitatively determined.
Assay for bacterial adherence to intact intestinal surface. Sections of guinea pig small intestine were obtained, washed with saline, and then opened by a longitudinal incision and placed on a flat plastic surface with the mucosa facing upward. A cover containing three oval holes with a surface area of 0.38 em? was screwed on the mucosal surface (13) . Radiolabeled bacteria (100 ttl, 2 x 10 9 bacteria/rnl) were preincubated with human milk or PBS (control) as described above, and then were placed on the exposed portion of the mucosa (13) . The preparation was incubated (45 min, 37°C) in a humid chamber and the reaction was then terminated by washing the tissue three times with saline. The tissue was taken out of the instrument and the radioactivity ofthe exposed mucosa with the adhered bacteria was determined (13) .
Stat istical methods. All the experiments were done in duplicates. Results represent mean SO. An F test analysis of variance, followed by the t test for multiple comparisons, were employed for the statistical analysis.
Scanning electron microscopy. After the assay for bacterial adherence, (with and without NIgF of human milk) the intestinal cells or intestinal mucosa were washed in saline, fixed with 2% glutaraldehyde for I h, and washed with 0.1 M sodium cacodylate buffer at pH 7.2. They were then incubated with I% osmium tetraoxide for 30 min and dried to a critical point. The tissue was fixed to planchets, coated with gold, and examined with a JSM-35c scanning electron microscope (Jeol, Japan).
possessed CFA/I and CFA/II, respectively, and were grown as described (6) . E. coli 0128:H4 was obtained from Dr. N. Gerber, Bar Han University, Israel, and was grown in I % peptone (Difco Laboratories, Detroit, MI), 0.5% yeast extract and 0.5% NaCl. It contained type I pili (14) and agglutinated mannan-containing yeast cells (12) .
Radiolabeled bacteria were prepared by metabolically labeling them with o-C 4 C) glucose (239 mCi/mmol, 0.1 Ci/rnl ; The Radiochemical Center, Amersham , England) as described (13) . The radioactivity of the labeled bacteria was counted in a Tricarb liquid scintillation spectrometer (model 3255, Packard Instrument Co., Downers Grove, IL) and the specific radioactivity obtained was approximately 10 6 counts/rnin/LO? bacteria. Precipitation in 5% trichloroacetic acid showed that more than 90% of the radiolabeled precursor was incorporated into macromolecular components of the bacteria. Human milk and colostrum specimens. Pooled human milk (4-14 days after delivery) and colostrum (2-3 days after delivery) were obtained from Israeli women at the Beilinson Medical Center. The fresh milk was centrifugated (10,000 x g, 15 min) and the clear middle layer was collected and separated from the upper and lower layers, which contained fat and cells, respectively, and frozen at -30°C. NIgF was obtained by passing the milk through an immunosorbent column which bound the immunoglobulins. The column consisted of a top layer of 2 ml Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, Sweden) covalently coupled with antihuman IgA (ex chain; Bioyeda, Rehovoth , Israel) and a bottom layer of 2 ml Sepharose coupled with antihuman -y-globulin (heavy and light chains; Bioyeda). Each ml agarose contained 1.2 mg Ig. The detailed procedures for preparation of the columns were as described (6, 17) . After passage through the column , the nonbound fraction was recirculated through the column three times and then dialyzed against saline. This fraction was shown to be depleted of the various classes of immunoglobulins by immunodiffusion on agarose (Ouchterlony) . In addition, the NIgF was devoid of any antibacterial Ig fraction as shown by the following experiment. Bacterial suspensions were incubated with NIgF, washed (x3), incubated (30 min, 20°C) with rabbit antihuman -y-globulin (IgA and IgG), washed (x S), and finally incubated (30 min, 20°C) with fluorescent goat anti rabbit -y-globulin (18) . Only the original human milk fractions showed binding of fluorescent antibodies to the bacteria, confirming that antibodies against the bacteria examined were found only in the original human milk sample (in I:10 dilution) and not in the NIgF. In order to quantitate this reaction and find out its sensitivity, experiments were done with increasing dilutions of the original human milk. It was found that this milk gave a positive reaction even at I: 100 dilution, indicating that this assay can detect as little as I% of human milk immunoglobulins. The final NIgF fraction was lyophilized to obtain the dry weight, and its protein and sugar content were determined as described (19, 20) .
Assay for bacterial adherence to viable intestinal cells. A suspension of intestinal cells was obtained by treating sections of the jejunum with solutions containing EDTA, citrate buffer, and dithiothreitol as described (13, 14) . The viability of the intestinal cells was monitored by trypan blue exclusion. Radiolabled bacteria (100 ttl, 2 x 10 9 bacteria/rnl) were preincubated (15 min , 37" C) with human milk [50-600 ttl, (1.1-13 .2 mg) according to the experiment] or the same volume of PBS in a rotating rack at 16 rpm. The bacteria were then incubated (45 min , 37" C) with the intestinal cells (200 ttl, 5 x 10 6 cells/rnl, 200 bacteria/cell) with rotation. It was shown that no significant proliferation of the bacteria occurred during these incubation periods. The reaction was terminated by adding 2.5 ml saline and centrifugation (500 x g, 5 min) to sediment the epithelial cells, while the supernatant, which contained mainly nonadherent bacteria, was discarded. The separation of the epithelial cells from the remaining nonadherent bacteria was performed by discontinuous density-gradient centrifugation with Percoll (Pharmacia Fine Chem- Quantitative determinations showed that (13.2-20.8) x 10 5 bacteria adhered to each area of the exposed jejunal mucosa (Table  3) . NIgF of human milk and colostrum caused 38 to 43% inhibition of the adherence of ETEC EI392 and H10407, but did not inhibit the adherence of E. coli 0128 (Table 3) as found in the previous experiments in vitro.
DISCUSSION
The main finding of this study is the significant inhibitory effect of NIgF of human milk on the adherence of ETEC to the small intestine. The inhibition was limited to bacteria whose
H 10407 0 128 Fig. 2 . The effect of NIgF of human milk and colostrum on the adherence of ETEC to guinea pig intestinal cells. Two hundred ,ul of human milk (4.5 mg) or PBS (control) were preincubated with radiolabeled bacteria (15 min, 37°C) and then the reaction was performed as described. Results represent mean ± SD of eight determinations. p values, calculated as compared to the control group, were significant for E. coli E 1392 (p < 0.001) and for E. coli0128 (p < 0.01).
D Control Human milk
ITIill Human colostrum inhibitory effect was examined (Fig. 3) . It was found that the inhibition increased as higher amounts were added, the maximal effect (59% inhibition) has achieved at 300 JLI (6.7 mg) of NIgF of human milk. Higher amounts ofNIgF of human milk did not increase the inhibition; moreover, it caused agglutination of the bacteria and therefore augmentated the number of the adhered bacteria.
In order to elucidate the mechanism of the inhibitory effects and find out the type of the involved compounds, several pretreatments ofNIgF human milk samples were undertaken. Heating (100°C, 10 min) and proteolytic digestion with trypsin (final concentration 2 mg/ml, 2 mg enzyme/ml of milk contained 22.4 mg of solids, of which proteins were 1.1 mg, 60-min incubation, and then boiling for 10 min to stop the enzymatic activity) did not abolish the inhibitory effect. In contrast, pretreatment of NIgF of human milk with sodium periodate (final concentration (24) have recently described a method of obtaining human intestinal cells from long-standing ileostomies (24) . Using this approach, similar determinations with human cells can be undertaken. Although considerable work is still needed and studies are in progress, it seems that a new mechanism by which human milk protects against intestinal infection may exist, as previously suggested by in vitro hemagglutination inhibition (6) . This protection of human milk is well documented (2-4) and was traditionally attributed to its Igcontent. However, Ig may be destroyed by intestinal digestive enzymes and their titer against intestinal pathogens is reduced in developed countries (6) . It was, for example, shown that immunoglobulins play only a minor role in the inhibitory activity of human milk obtained from Swedish mothers against E. coli (6) and V. cholerae (21) adhesion to erythrocytes.
We have recently shown that bacterial adherence to the intestinal tract depends on the postnatal age and it may playa role in the development of the normal bacterial flora and the appearance of intestinal infections (14, 25) . Infections with ETEC are important in infancy and depend on the adherence of the bacteria to the gut (18) . Since our results show that human milk can inhibit the adherence of certain ETEC strains to the gut, it is suggested that this mechanism may play a role in protecting infants against intestinal infections.
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